The US Food and Drug Administration (FDA) has recommended removing certain warning statements and modifications of the instructions for the use of over-the-counter (OTC) nicotine replacement therapy (NRT) products. Commending FDA ...
Tags: FDA, Nicotine Medications Labeling, Medicine
AkzoNobel is pleased to announce its involvement in an important new initiative to inspire young people into careers in the manufacturing sector. Leading global paints and coatings company AkzoNobel is joining an exclusive group of ...
Tags: AkzoNobel, paints company, coatings company
GlaxoSmithKline (GSK) is closing its Sirtris Pharmaceuticals office in Cambridge and fully integrating its research and development (R&D) operations with Philadelphia office. The firm is mulling to relocate some of the 60 staffers ...
The Cyber Security Challenge (CSC) is not only about recruiting talent, but is aimed at raising awareness and widening the IT security talent pool, according to the competition's CEO, Stephanie Danan. Danan was responding to Computing's ...
Tags: Cyber Security, IT security, cyber
The food industry’s biggest ever takeover was announced over the past month with the sale of Heinz to a consortium led by the sage of Omaha, Warren Buffett, and Brazilian private equity specialist Jorge Lemann’s 3G Capital group ...
The Cyber Security Challenge, a series of national events designed to encourage talented professionals to join the UK IT security industry, has just announced its latest winner, 28-year-old chemist Stephen Miller. Government cyber ...
Tags: Cyber Security Challenge, IT security industry, cyber security
Yammer plans to roll out an integration with the SkyDrive Pro cloud storage product and the Office Web Apps Web-hosted productivity application suite this summer. The initiative is part of Yammer's push to deepen and extend the ...
Tags: Yammer, cloud storage product, Web Apps
The USFDA has granted priority review designation to ViiV Healthcare's dolutegravir as a candidate with the potential to treat HIV infection in combination with other antiretroviral agents, in adolescents and adults. The dolutegravir new ...
Tags: infection therapy, Healthcare, FDA
GlaxoSmithKline (GSK) has submitted marketing authorisation application, to the European Medicines Agency, for trametinib (MEK) as monotherapy and dabrafenib (BRAF)/MEK combination therapy in metastatic melanoma. The application was ...
Tags: GSK, metastatic melanoma therapy, Medicines
GlaxoSmithKline and Theravance have announced the MAA submission for Anoro in Europe for patients with chronic obstructive pulmonary disease (COPD). The COPD therapy, administered using the ELLIPTA inhaler, is a combination of GSK573719 ...
Tags: GlaxoSmithKline, COPD therapy, chronic obstructive pulmonary disease
Galapagos has reached a milestone in its immuno-inflammation alliance with GlaxoSmithKline (GSK) by delivering a fifth pre-clinical drug candidate. Galapagos CEO Onno van de Stolpe said the company has identified five candidate drugs of ...
Tags: immuno inflammation, GSK, clinical drug, drug
Priaxon has signed research collaboration with GlaxoSmithKline (GSK) to develop small molecule modulators for various protein-protein-interactions (PPIs). The collaboration will utilize Priaxon's small molecule drug discovery knowledge in ...
Tags: Priaxon, GSK, drug discovery, clinical development, therapeutic areas
GlycoVaxyn and GlaxoSmithKline Biologicals(GSK)have signed a research partnership for the development of new bacterial vaccines. The collaboration,planned for three years,will leverage GlycoVaxyn's bio-conjugation technology in developing ...
Tags: GSK, Glycovaxyn, bacterial vaccines, Partnership
GlaxoSmithKline (GSK) and Theravance have submitted a regulatory application in the US for the investigational once-daily LAMA/LABA combination medicine, umeclidinium bromide (UMEC/VI), to treat chronic obstructive pulmonary disease (COPD) ...
Tags: GlaxoSmithKline, regulatory application, Medicine, FDA
NeRRe Therapeutics is established as a new drug discovery company for the development of a range of clinical and pre-clinical neurokinin antagonists separated from GlaxoSmithKline(GSK). The company,based at Stevenage Bioscience ...
Tags: NeRRe Therapeutics, GSK, pre-clinical neurokinin antagonists